Your browser doesn't support javascript.
loading
Mendelian randomization reveals interactions of the blood proteome and immunome in mitral valve prolapse.
Minvielle Moncla, Louis-Hippolyte; Briend, Mewen; Sokhna Sylla, Mame; Mathieu, Samuel; Rufiange, Anne; Bossé, Yohan; Mathieu, Patrick.
Afiliação
  • Minvielle Moncla LH; Genomic Medicine Laboratory, Quebec Heart and Lung Institute, Laval University, Quebec City, QC, Canada.
  • Briend M; Genomic Medicine Laboratory, Quebec Heart and Lung Institute, Laval University, Quebec City, QC, Canada.
  • Sokhna Sylla M; Genomic Medicine Laboratory, Quebec Heart and Lung Institute, Laval University, Quebec City, QC, Canada.
  • Mathieu S; Genomic Medicine Laboratory, Quebec Heart and Lung Institute, Laval University, Quebec City, QC, Canada.
  • Rufiange A; Genomic Medicine Laboratory, Quebec Heart and Lung Institute, Laval University, Quebec City, QC, Canada.
  • Bossé Y; Department of Molecular Medicine, Laval University, Quebec City, QC, Canada.
  • Mathieu P; Genomic Medicine Laboratory, Quebec Heart and Lung Institute, Laval University, Quebec City, QC, Canada. patrick.mathieu@fmed.ulaval.ca.
Commun Med (Lond) ; 4(1): 108, 2024 Jun 06.
Article em En | MEDLINE | ID: mdl-38844506
One cause of heart disease is mitral valve prolapse, where heart valve thickening leads to malfunction. Biological factors that contribute to this occurrence are largely unknown. We took advantage of different public resources and independent datasets to conduct different converging analyses to identify relevant biological factors. Using genetic variation, we implemented a technique to assess the role of circulating blood proteins on the risk of the disease. We report that blood proteins involved in the regulation of the immune response promote a dysfunctional tissue repair process of the mitral valve. This study has highlighted a contribution of blood proteins that promote excessive tissue repair leading to mitral valve dysfunction. Several of the identified proteins are potential pharmacological targets that could be singled out in future efforts to halt the progression of the disease.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article